Also trades as: RGBPP (OTC) · $vol 0M
RGBP OTC
Regen BioPharma, Inc.
1W: +40.0%
1M: +13900.0%
3M: +40.0%
YTD: -98.4%
1Y: -98.9%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±8730.1%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships0
As Filer
counterparties named
5
As Counterparty
mentioned by others
2021-04-16
Earliest Filing
2025-10-03
Latest Filing
Mentioned As Counterparty
5 mentionsOther companies that named RGBP in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| RGBPP Regen BioPharma Inc | target | Company entering into consulting agreement for Phase I Clinical Trial of HemaXellerate | 2025-10-03 | View |
| RGBPP Regen BioPharma Inc | supplier | Issuer of the promissory note and borrower of funds | 2025-08-07 | View |
| RGBPP Regen BioPharma Inc | partner | Issuer of the 5% Promissory Note | 2021-09-24 | View |
| RGBPP Regen BioPharma Inc | customer | Agreed to pay $800,000 settlement to Chemdiv, Inc. contingent on SEC filing requirements. | 2021-09-16 | View |
| RGBPP Regen BioPharma Inc | partner | Counterparty in amendment; licensor and issuer of convertible notes | 2021-04-16 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR